SL

Shanta Laxmikant Chaudhary

Active Director Director DIN 07462899
DIN 07462899 First appointment Mar 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Shanta Laxmikant Chaudhary

Data last updated:

Shanta Laxmikant Chaudhary is a Director at Outcomes Pharma Private Limited (since 2016). The company operates in Pharma.

DIN 07462899
Primary Designation Director
Industry Pharma
First Appointment 09 Mar 2016
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Outcomes Pharma Private Limited U74120MH2013PTC244961
Director09 Mar 20162013Active

Board colleagues of Shanta Laxmikant Chaudhary

Directorship timeline

Open interactive timeline →
Outcomes Pharma Private Limited
Premium access

Shareholding and investment profile for Shanta Laxmikant Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanta Laxmikant Chaudhary

Shanta Laxmikant Chaudhary currently holds 1 directorship: Outcomes Pharma Private Limited (Director, since 09 Mar 2016).

Shanta Laxmikant Chaudhary was first appointed on 09 Mar 2016 as Director at Outcomes Pharma Private Limited.

The current boards of Shanta Laxmikant Chaudhary's companies include Anand Laxmikant Chaudhari (Outcomes Pharma Private Limited), Sham Laxmikant Chaudhari (Outcomes Pharma Private Limited), Tejal Anand Chaudhari (Outcomes Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available